Stockreport

Fate Therapeutics' Lupus Candidate FT819 Gets FDA RMAT Tag [Yahoo! Finance]

Fate Therapeutics, Inc.  (FATE) 
Last fate therapeutics, inc. earnings: 3/2 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.fatetherapeutics.com/investor-relations
PDF pipeline candidate FT819 for the treatment of active moderate to severe systemic lupus erythematosus (SLE), including lupus nephritis. The RMAT designation provides th [Read more]